Anbio Biotechnology

Anbio Biotechnology (NNNN) shows no cyber incidents or major red-flag filings in our 90-day ingestion window, but low signal during a recent period doesn't indicate low structural risk. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scores based on equity issuance patterns, and maps financing history alongside AI-flagged risk signals that shorter windows miss. You'll also get detailed 8-K context and officer change tracking across the full period. The full $49 Report adds 12-month risk scoring, dilution analysis, complete financing timeline, and AI-detected anomalies beyond the current window.